The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab.

MLA

Degens, Juliette H. R. J., et al. “The Prognostic Value of Weight and Body Composition Changes in Patients with Non-Small-Cell Lung Cancer Treated with Nivolumab.” Journal of Cachexia, Sarcopenia and Muscle, vol. 12, no. 3, June 2021, pp. 657–64. EBSCOhost, https://doi.org/10.1002/jcsm.12698.

APA

Degens, J. H. R. J., Dingemans, A.-M. C., Willemsen, A. C. H., Gietema, H. A., Hurkmans, D. P., Aerts, J. G., Hendriks, L. E. L., & Schols, A. M. W. J. (2021). The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab. Journal of Cachexia, Sarcopenia and Muscle, 12(3), 657–664. https://doi.org/10.1002/jcsm.12698

Chicago

Degens, Juliette H R J, Anne-Marie C Dingemans, Anna C H Willemsen, Hester A Gietema, Daan P Hurkmans, Joachim G Aerts, Lizza E L Hendriks, and Annemie M W J Schols. 2021. “The Prognostic Value of Weight and Body Composition Changes in Patients with Non-Small-Cell Lung Cancer Treated with Nivolumab.” Journal of Cachexia, Sarcopenia and Muscle 12 (3): 657–64. doi:10.1002/jcsm.12698.